Novo Nordisk Foundation pledges $57 million to WHO amid US funding gap
May 21 (Reuters) - The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to expand its tie-up with the United Nations agency for another four years, the philanthropic body said on Wednesday.
WHO said on Tuesday it had secured over $170 million in new commitments from multiple countries and organizations, but did not disclose the amount contributed by the foundation, which owns a controlling stake in drugmaker Novo Nordisk (NOVOb.CO), opens new tab.
The pledge comes at a time when the WHO faces a major funding shortfall with the planned withdrawal of the United States, its largest donor.
The Novo Nordisk Foundation said it is expanding its collaboration to focus on non-communicable diseases, antimicrobial resistance and health system resilience.
Novo Holdings, the foundation's investment arm, is one of the world's biggest philanthropic donors.
The U.S. is set to exit the agency in 2026 following President Donald Trump's decision, announced on his first day in office.
In response, WHO has cut its 2026–2027 budget by 20% to $4.2 billion and will raise mandatory member contributions by 20%, with China becoming the top state donor.
"WHO plays a unique role in the global health ecosystem, providing normative guidance, monitoring diseases, building country capacity for resilient health systems and supporting learning and evidence," said Mads Krogsgaard Thomsen, CEO of the foundation.
($1 = 6.5761 Danish crowns)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
24 minutes ago
- Sky News
Blood test for Alzheimer's disease is highly accurate, researchers say
Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - and found the test was 95% accurate in identifying patients with existing cognitive impairment linked to the condition. The US study involved 509 patients in an outpatient memory clinic in Florida and was published in the medical journal Alzheimer's and Dementia. The test, which has already been approved by the US regulator, was also 82% accurate for specificity, which means it could rule out people without dementia. Dr Gregg Day, who led the study, said the test was as good as existing, but more invasive, tests. He said the next step was to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms. Scientists say the two proteins, which they have identified in blood plasma, are associated with the buildup of amyloid plaques. Amyloid protein can be found in our brains, but in Alzheimer's disease, amyloid sticks together and forms abnormal deposits, which are thought to be toxic to brain cells. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results "suggest this test is very accurate". "Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before," he added. In the UK, the Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. 1:09 Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal." She said the studies like the Blood Biomarker Challenge are a "crucial part of making diagnosis easier and faster, which will bring us closer to a cure". "The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK," she added.
The Guardian
2 hours ago
- The Guardian
Switch on those glutes! Suddenly it's all about the bass, and for good reason
I'm staring at the screen, trying to write a joke. It involves a muscle called the gluteus maximus, Roman centurions and possibly a reference to Biggus somebody from Monty Python's Life of Brian. I've been sitting here for over an hour, so long that when I finally stand up I have to hobble and wobble a few steps before I can get my stride back. It's because my glutei maximi are a bit of a joke. I have spent so much of my life literally sitting on this Roman-sounding muscle, staring at screens, trying to think up killer first lines to stories that by middle-age this undernourished workhorse is vocalising its disappointment at my life choices. Everyone seems to be talking about glutes right now and it's not just some fad brought on by Kim Kardashian's internet-breaking bum. Fitness instructors tell us to 'switch on those glutes', or admonish us for having 'lazy' glutes or 'dead butt syndrome'; suddenly, it's all about the bass. And it's for good reason. The gluteal muscles are vital for getting us up and about, yet humanity's increasingly sedentary lifestyle and work are leading to neglect of our glute health, with potentially serious consequences for our overall health. Let's meet the triumvirate of the tush muscles: gluteus maximus, gluteus medius and gluteus minimus. Maximus is, as the name suggests, the big one that makes up what might colloquially be known as the butt cheek and which attaches at the back of the pelvis and at the side of the thigh bone. 'Glute max is largely responsible for extending your hips, so pushing your leg behind you,' says associate professor Angie Fearon, a physiotherapist at the University of Canberra. 'If you're standing up and you pushed your leg backwards, that would be that muscle … it pushes you forwards when you're walking, or running or hopping or skipping.' Gluteus medius and minimus take the leg out to the side and manage the rotational movement. These three muscles are vital in keeping the pelvis stable during walking, lifting the leg up and powering us forward. They are also a link from the core muscles in the stomach and the lower back down to the muscles of the legs. Weak gluteal muscles can lead to what Dr Charlotte Ganderton describes as a teapot-style gait, where people tilt their upper body from side to side over their hip as they walk. 'They're actually throwing their whole torso over their hip to be able to clear their foot through, and that obviously has significant consequences on the rest of your body and the joints that are further up from the hip, so the spine,' says Ganderton, a physiotherapist at RMIT and Alphington Sports Medicine in Melbourne. The real problem with neglected gluteal muscles is what they can lead to. 'If you don't have good functioning gluteal muscles, the actual hip joint is the one who takes on those forces,' Ganderton says. 'People that have hip pathology – so hip arthritis, lateral hip pain, which people call gluteal tendinopathy – we know that these individuals have poor hip strength, and they often have very poor hip control when we assess them in the clinic.' The two most common hip conditions that affect particularly older people are hip osteoarthritis and gluteal tendinopathy, which is sometimes also called greater trochanteric pain syndrome or bursitis. 'What we see in people with those conditions is they're often weaker in that area than an asymptomatic control group,' Fearon says. With gluteal tendinopathy, pain develops because weaker gluteal muscles leads people to overuse other muscles, which then cause irritation and inflammation of the tendons and muscles in the outer hip region. And for many, our sedentary lifestyle is to blame – it is very much a case of 'use it or lose it'. Even two weeks of sitting on our backsides with little to no activity can be enough to start deconditioning and diminishing of our muscles. Further on from that, 'the muscle no longer stays as muscle tissue, for the most part – it actually fills with fat and what we call fatty infiltrate', Ganderton says. And once that happens, it can be very challenging to reverse and rebuild the muscle. However the exercises to strengthen the gluteal muscles are actually pretty basic. The simplest one is called a 'gluteal bridge' and just involves lying on your back, planting the soles of your feet on the floor or bed and lifting your pelvis up off that surface. Or while you're lying down, roll on to your side and lift the upper leg upwards to about the width of your shoulders. Ganderton's own research in postmenopausal women with gluteal tendinopathy found that a simple standing exercise could also help. 'Standing on one leg where you've got both knees straight and you just lift up the opposite leg about a centimetre off the floor, so just weight shifting across uses a lot of muscle activity in the leg that's standing on the ground,' she says. For the more active and stable among us, Fearon also recommends squats and walking lunges, carrying weights if you're up to it. Even these simple exercises can make a big difference, Fearon says. 'Say you had 100 people with gluteal tendinopathy, in a large percentage of them, if you got them to do some specific strengthening work for the hip abductors, and you gave them some suitable education, they'd probably all improve or a large percentage of them would.' But at the most basic level, we just need to move more. 'There's really good evidence that shows that if you get up and move every 20 to 30 minutes – get up, do a few squats, go and get a glass of water, go to the photocopier, just get up and move – it actually sets off a whole lot of enzymes in your muscles, which is good,' she says. 'Your brain gets a break and overall you do better.'
Daily Mail
3 hours ago
- Daily Mail
Statins almost halve the risk of death in patients critically ill with sepsis
Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.
